Date | Time | Source | Announcement |
---|---|---|---|
15 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
14 Nov 2002 | 03:00 PM | Directorate Change | |
14 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
13 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
11 Nov 2002 | 07:00 AM | Purchase of Own Securities | |
07 Nov 2002 | 08:30 AM | Annual Review | |
07 Nov 2002 | 07:00 AM | Crestor | |
05 Nov 2002 | 01:00 PM | Omeprazole Judgment Appeal | |
28 Oct 2002 | 07:00 AM | Exanta Express | |
24 Oct 2002 | 11:00 AM | 3rd Quarter Results-Part 2 | |
24 Oct 2002 | 11:00 AM | 3rd Quarter Results-Part 1 | |
23 Oct 2002 | 09:00 AM | Notice of Results | |
22 Oct 2002 | 11:49 AM | Omeprazole Patent Ruling | |
14 Oct 2002 | 07:06 AM | Prilosec Patents Ruling | |
30 Sep 2002 | 04:00 PM | Holding(s) in Company | |
25 Sep 2002 | 07:01 AM | Iressa | |
16 Sep 2002 | 07:00 AM | Symbicort | |
12 Sep 2002 | 07:00 AM | Purchase of Own Securities | |
11 Sep 2002 | 03:00 PM | Capital Group | |
11 Sep 2002 | 07:00 AM | Purchase of Own Securities | |
10 Sep 2002 | 07:00 AM | Purchase of Own Securities | |
06 Sep 2002 | 07:00 AM | Arimidex | |
06 Sep 2002 | 07:00 AM | Purchase of Own Securities | |
05 Sep 2002 | 07:00 AM | Purchase of Own Securities | |
04 Sep 2002 | 07:00 AM | Purchase of Own Securities | |
02 Sep 2002 | 07:00 AM | Purchase of Own Securities | |
02 Sep 2002 | 07:00 AM | Crestor Data | |
30 Aug 2002 | 07:00 AM | Purchase of Own Securities | |
22 Aug 2002 | 07:00 AM | Purchase of Own Securities | |
21 Aug 2002 | 07:00 AM | Purchase of Own Securities | |
19 Aug 2002 | 11:30 AM | Iressa Announcement | |
15 Aug 2002 | 07:00 AM | Purchase of Own Securities | |
14 Aug 2002 | 07:00 AM | Purchase of Own Securities | |
12 Aug 2002 | 07:00 AM | Purchase of Own Securities | |
09 Aug 2002 | 07:00 AM | Purchase of Own Securities | |
08 Aug 2002 | 07:00 AM | Purchase of Own Securities | |
07 Aug 2002 | 01:00 PM | Iressa | |
06 Aug 2002 | 02:00 PM | Update on Crestor | |
25 Jul 2002 | 11:00 AM | Interim Results - Part 2 | |
25 Jul 2002 | 11:00 AM | Interim Results - Part 1 | |
24 Jul 2002 | 09:00 AM | Notice of Results | |
05 Jul 2002 | 07:13 AM | Iressa In Japan | |
28 Jun 2002 | 07:00 AM | Purchase of Own Securities | |
27 Jun 2002 | 07:00 AM | Purchase of Own Securities | |
26 Jun 2002 | 07:00 AM | Purchase of Own Securities | |
25 Jun 2002 | 07:00 AM | Purchase of Own Securities | |
24 Jun 2002 | 07:00 AM | Purchase of Own Securities | |
21 Jun 2002 | 07:00 AM | Research Update | |
17 Jun 2002 | 07:00 AM | Purchase of Own Securities | |
14 Jun 2002 | 07:00 AM | Purchase of Own Securities |
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Astra Zeneca share price launched at 605p in 1993.